![Three-year Follow up of GMCSF/bi-shRNAfurin DNA-transfected Autologous Tumor Immunotherapy (Vigil) in Metastatic Advanced Ewing's Sarcoma: Molecular Therapy Three-year Follow up of GMCSF/bi-shRNAfurin DNA-transfected Autologous Tumor Immunotherapy (Vigil) in Metastatic Advanced Ewing's Sarcoma: Molecular Therapy](https://www.cell.com/cms/attachment/5bce48f4-5d8b-4f4a-bcfb-b55f0b7a9a28/gr1_lrg.jpg)
Three-year Follow up of GMCSF/bi-shRNAfurin DNA-transfected Autologous Tumor Immunotherapy (Vigil) in Metastatic Advanced Ewing's Sarcoma: Molecular Therapy
![Cureus | A Deep Dive Into the Newest Avenues of Immunotherapy for Pediatric Osteosarcoma: A Systematic Review Cureus | A Deep Dive Into the Newest Avenues of Immunotherapy for Pediatric Osteosarcoma: A Systematic Review](https://assets.cureus.com/uploads/figure/file/246471/lightbox_c1747cb0f40611ebb741a9a1e985fb6f-Add-a-little-bit-of-body-text-12.png)
Cureus | A Deep Dive Into the Newest Avenues of Immunotherapy for Pediatric Osteosarcoma: A Systematic Review
![Immunotherapy for sarcomas: new frontiers and unveiled opportunities | Journal for ImmunoTherapy of Cancer Immunotherapy for sarcomas: new frontiers and unveiled opportunities | Journal for ImmunoTherapy of Cancer](https://jitc.bmj.com/content/jitc/9/2/e001580/F1.large.jpg)
Immunotherapy for sarcomas: new frontiers and unveiled opportunities | Journal for ImmunoTherapy of Cancer
![Immunotherapy vs. Ewing Sarcoma: LET'S GO! — Little Warrior Foundation | Find the Cure for Childhood Cancer Immunotherapy vs. Ewing Sarcoma: LET'S GO! — Little Warrior Foundation | Find the Cure for Childhood Cancer](http://static1.squarespace.com/static/5de28c8008114a27bbd10042/5f48257d18e160050b29d7e5/61ba7bc5dc340c374dc4e6df/1639674937976/851CBEAB-1913-4CC8-863C-BF92717C2FAD.jpeg?format=1500w)
Immunotherapy vs. Ewing Sarcoma: LET'S GO! — Little Warrior Foundation | Find the Cure for Childhood Cancer
![Cancers | Free Full-Text | Heterogeneous Circulating Tumor Cells in Sarcoma: Implication for Clinical Practice Cancers | Free Full-Text | Heterogeneous Circulating Tumor Cells in Sarcoma: Implication for Clinical Practice](https://www.mdpi.com/cancers/cancers-13-02189/article_deploy/html/images/cancers-13-02189-g001.png)
Cancers | Free Full-Text | Heterogeneous Circulating Tumor Cells in Sarcoma: Implication for Clinical Practice
![Hsieh Lab on Twitter: "Very interesting work from the @AsanganiLab in Ewing Sarcoma linking it's pathognomonic fusion protein with LOXHD1." / Twitter Hsieh Lab on Twitter: "Very interesting work from the @AsanganiLab in Ewing Sarcoma linking it's pathognomonic fusion protein with LOXHD1." / Twitter](https://pbs.twimg.com/media/Eu8DKVIU4AQrqic.png)
Hsieh Lab on Twitter: "Very interesting work from the @AsanganiLab in Ewing Sarcoma linking it's pathognomonic fusion protein with LOXHD1." / Twitter
![Management of recurrent or refractory Ewing sarcoma: A systematic review of phase II clinical trials in the last 15 years Management of recurrent or refractory Ewing sarcoma: A systematic review of phase II clinical trials in the last 15 years](https://www.spandidos-publications.com/article_images/ol/18/1/ol-18-01-0348-g00.jpg)
Management of recurrent or refractory Ewing sarcoma: A systematic review of phase II clinical trials in the last 15 years
![Chimeric antigen receptor T (CAR-T) cell immunotherapy for sarcomas: From mechanisms to potential clinical applications - Cancer Treatment Reviews Chimeric antigen receptor T (CAR-T) cell immunotherapy for sarcomas: From mechanisms to potential clinical applications - Cancer Treatment Reviews](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/3609e4eb-98ce-4f15-aead-bcd7844dad0e/gr1_lrg.jpg)
Chimeric antigen receptor T (CAR-T) cell immunotherapy for sarcomas: From mechanisms to potential clinical applications - Cancer Treatment Reviews
![Is immunotherapy in the future of therapeutic management of sarcomas? | Journal of Translational Medicine | Full Text Is immunotherapy in the future of therapeutic management of sarcomas? | Journal of Translational Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12967-021-02829-y/MediaObjects/12967_2021_2829_Fig3_HTML.png)